SCHEMBL6428548

SCHEMBL6428548

O=C1C(c2ccc(Cl)cc2)=C(C(F)(F)F)C(=O)N1Cc1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 4/20 0.56
NR1H3 Q13133 4/20 0.56
ALDH1A1 P00352 2/20 0.42
ALDH2 P05091 1/20 0.42
ALDH3A1 P30838 1/20 0.42
F2 P00734 1/20 0.41
PLG P00747 1/20 0.41
ELANE P08246 1/20 0.41
CTSG P08311 1/20 0.41
CMA1 P23946 1/20 0.41
CTRC Q99895 1/20 0.41
CASP3 P42574 1/20 0.41
CES2 O00748 1/20 0.40
BCHE P06276 1/20 0.40
CES1 P23141 1/20 0.40
SIRT2 Q8IXJ6 1/20 0.40
PRKAG1 P54619 1/20 0.40
PRKAA2 P54646 1/20 0.40
PRKAB1 Q9Y478 1/20 0.40
PIM1 P11309 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6427122 0.93 NR1H2 (0.47) NR1H2NR1H3ALDH1A1CES2BCHE
SCHEMBL6427820 0.90 KMT2A (0.47) NR1H2NR1H3ALDH1A1NPSR1MEN1
SCHEMBL6426786 0.88 MAPT (0.46) NR1H2NR1H3ALDH1A1CASP3CES2
SCHEMBL6426783 0.85 NR1H2 (0.47) NR1H2NR1H3ALDH1A1F2PLG
SCHEMBL6426703 0.84 NR1H2 (0.41) NR1H2NR1H3ALDH1A1CES2BCHE
SCHEMBL6463014 0.84 CMA1 (0.51) NR1H2NR1H3ALDH1A1CMA1NPSR1
SCHEMBL6429024 0.83 PTGS2 (0.46) NR1H2NR1H3
SCHEMBL6427166 0.83 CASP1 (0.47) NR1H2NR1H3ALDH1A1CASP3MEN1
SCHEMBL6525603 0.79 NR1H2 (0.41) NR1H2NR1H3ALDH1A1ALDH2ALDH3A1
SCHEMBL6427487 0.79 DHPS (0.46) NR1H2NR1H3ALDH1A1LMNAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005024755-A2 MEDICAMENTS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS OR DIABETES DECIPHERA PHARMACEUTICALS, LLC. (US) 2005-03-17 WO disclosed